Dr. McNeil is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8080 Ravines Edge CT
200
Columbus, OH 43235Phone+1 614-430-3030Fax+1 855-656-7325
Summary
- Dr. McNeil’s private practice is located at Midwest Allergy Asthma and Immunology Associates in Worthington, Ohio. He also travels to Midwest Allergy’s offices in Zanesville, Chillicothe and Newark.
Of special interest to Dr. McNeil are patients who have immune deficiencies or angioedema. He has traveled widely to speak about angioedema and meet patients with all types of the condition.
Dr. McNeil is an Associate Professor of Clinical Medicine at The Ohio State University and does Allergy Training for the OSU ENT Residency Program. In addition to being on the medical teaching staff of Mt. Carmel, Doctors and Riverside Methodist Hospitals, Dr. McNeil is also on the consulting staff of Grant Hospital in Columbus and Bethesda Hospital in Zanesville, Ohio. A member of the American College of Physicians, Dr. McNeil is board certified in allergy, immunology and internal medicine. He has published numerous articles related to asthma, allergy and immunology.
Dr. McNeil is president, founder, and principal investigator at Optimed Research, and has over 20 years of research experience. Certified as a clinical investigator since June, 2005, Dr. McNeil has conducted research studies in the following areas: Pneumonia, sinusitis, bronchitis, CVID, allergic rhinitis, rheumatoid arthritis, hyperlipidemia, hypercholesterolemia, osteoarthritis pain, hereditary angioedema, diabetes, and asthma.
Dr. McNeil founded Optimed Infusion LLC. in 1999 and is the Medical Director. He provides oversight of the infusion clinic, which administers IVIg treatments to patients with immunodeficiency in the Columbus, Ohio area.
Education & Training
- University of AlbertaClass of 1974
Certifications & Licensure
- CA State Medical License 1984 - Present
- OH State Medical License 1986 - 2026
- IL State Medical License 1987 - 1990
- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Clinical Trials
- Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema Start of enrollment: 2010 Feb 01
- Octagam 5% Versus Comparator Post Marketing Trial Start of enrollment: 2013 May 21
- Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE Start of enrollment: 2016 Mar 03
- Join now to see all
Publications & Presentations
PubMed
- 115 citationsEDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedemaRobyn J. Levy, William R. Lumry, Donald L. McNeil, H. Henry Li, Marilyn Campion
Annals of Allergy, Asthma & Immunology. 2010-06-01 - 202 citationsEcallantide for the treatment of acute attacks in hereditary angioedema.Marco Cicardi, Robyn J. Levy, Donald L. McNeil, H. Henry Li, Albert L. Sheffer
The New England Journal of Medicine. 2010-08-04 - 6 citationsTowards an FDA-cleared basophil activation test.Oral Alpan, Richard L Wasserman, Theodore Kim, Amy Darter, Atul Shah
Frontiers in Allergy. 2022-01-01
Press Mentions
- New York Times Retracts Massive Exaggeration of Children Hospitalized by COVID-19October 8th, 2021
- The Lab Leak Hypothesis, ExplainedJune 7th, 2021
- Covid-19 Live Updates: Volunteers to Be Infected in Vaccine StudyOctober 20th, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: